Agreed. I think maintaining capital to reduce risk of capital raising has most likely pressured management to keep ingredient costs down until deals have been sign and sealed. Obviously my own opinion.
Agree China is always a risk, but BUBs has always been pursuing US without issue to date.
Happy to continue to hold Long Term.
Ann: FY22 Q3 - Activity Report and Appendix 4C Cashflow Statement, page-35
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.010(7.41%) |
Mkt cap ! $111.5M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 12.5¢ | $644.4K | 4.918M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 2537508 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 270766 | 6 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| BUB (ASX) Chart |